ここから本文です
Yahoo!ファイナンス
投稿一覧に戻る

ネクセラファーマ(株)【4565】の掲示板 2016/11/18〜2016/11/20

on its way to becoming a blockbuster inhaler with more than $1bn [£810m] in annual sales,” said analysts at Numis Securities. “We estimate this increases the addressable market [in this area] to $10bn.”